CompoSecure Reports Record Third Quarter 2022 Financial Results and Raises 2022 Guidance
CompoSecure, Inc. (CMPO) reported Q3 2022 financial results, revealing a remarkable 56% year-over-year increase in net sales, reaching a record $103.3 million. Net income rose by 17% to $21.9 million or $0.18 EPS. The company raised its 2022 net sales guidance, now expecting $370-$380 million, along with an improved adjusted EBITDA outlook of $130-137 million. The success is attributed to strong demand for premium metal cards and operational efficiencies, with international sales up 35%.
- Net sales increased 56% YoY to $103.3 million.
- Net income rose 17% YoY to $21.9 million.
- Adjusted EBITDA increased 33% YoY to $32.7 million.
- Raised 2022 net sales guidance to $370-$380 million.
- Raised 2022 adjusted EBITDA outlook to $130-137 million.
- International net sales grew more than 35% YoY.
- Total debt stands at $373.1 million, which may raise financial concerns.
-
- Net Income up
- Adjusted EBITDA up
- Expects 2022 Net Sales at the High End of Guidance; Raises 2022 Adjusted EBITDA Outlook -
He added, “In addition, the Company has achieved better than anticipated profitability with Net Income up
“Based on our strong performance year-to-date, we are narrowing the Net Sales guidance range to the high end of our previously announced guidance and now expect
Q3 2022 Financial Highlights (vs. Q3 2021)
-
Net Sales :Net Sales increased56% to compared to$103.3 million , with the increase primarily driven by continued growth in the Company’s premium payment card business, customer expansion and international demand.$66.2 million -
Gross Profit: Gross Profit increased
71% to or$61.8 million 59.8% ofNet Sales , compared to or$36.1 million 54.6% . The increase in Gross Profit and margin was primarily driven by higher card issuance volumes and operational efficiencies. -
Net Income/EPS: Net Income increased
17% to compared to$21.9 million . Net Income per share attributable to class A common stockholders was$18.7 million per basic and diluted share.$0.18 -
Adjusted Net Income/Adjusted EPS: Adjusted Net Income (a non-GAAP measure) was
. Adjusted EPS (a non-GAAP measure), which includes both class A and class B shares, was$19.8 million per basic share and$0.26 per diluted share (see reconciliation of non-GAAP measures shown in table below).$0.22 -
Adjusted EBITDA: Adjusted EBITDA (a non-GAAP measure) increased
33% to compared to$32.7 million , with the increase primarily driven by$24.6 million Net Sales growth and margin expansion, as well as managing investments based on growth expectations. -
Balance Sheet: As of
September 30, 2022 , the Company had approximately of cash and cash equivalents and$15.4 million of total debt, which includes approximately$373.1 million of term loan,$233 million of revolver, and$10 million of exchangeable notes.$130 million -
Shares Outstanding: As of
September 30, 2022 , the Company had approximately 76.3 million shares outstanding which includes approximately 15.8 million class A shares and 60.6 million class B shares (for more information on shares outstanding, both basic and diluted, please refer to our 10-Q and the accompanying earnings presentation).
Recent Operational Highlights
- Strong domestic growth in payment card business including new clients across banking, gaming, fintech, entertainment and exchanges.
-
International
Net Sales up more than35% year-over-year to , primarily driven by strong demand for premium payment cards and growth in distributor channels.$19.5 million -
Added
Walmart.com and Newegg.com as distribution channels for the Arculus cold storage wallet. -
Appointed fintech and banking veteran
Paul Galant to the Company’s Board of Directors.
2022 Financial Outlook
The Company is narrowing its
Conference Call
The Company will host a conference call and live audio webcast today at
Date:
Time:
Dial-in registration link: here
Live webcast registration link: here
If you have any difficulty registering or connecting with the conference call, please contact Elevate IR at (720) 330-2829.
A live webcast and replay of the conference call will be available on the investor relations section of the Company’s website at https://ir.composecure.com/news-events/events.
About
Founded in 2000,
Forward-Looking Statements
This press release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. These statements are based on the beliefs and assumptions of management. Although the Company believes that its plans, intentions, and expectations reflected in or suggested by these forward-looking statements are reasonable, the Company cannot assure you that it will achieve or realize these plans, intentions, or expectations. Forward-looking statements are inherently subject to risks, uncertainties, and assumptions. Generally, statements that are not historical facts, including statements concerning the Company’s possible or assumed future actions, business strategies, events, or results of operations, are forward-looking statements. In some instances, these statements may be preceded by, followed by or include the words “believes,” “estimates,” “expects,” “projects,” “forecasts,” “may,” “will,” “should,” “seeks,” “plans,” “scheduled,” “anticipates” or “intends” or the negatives of these terms or variations of them or similar terminology. Forward-looking statements are not guarantees of performance. You should not put undue reliance on these statements which speak only as of the date hereof. You should understand that the following important factors, among others, could affect the Company’s future results and could cause those results or other outcomes to differ materially from those expressed or implied in the Company’s forward-looking statements: the outcome of any legal proceedings that may be instituted against the Company or others; the impacts of the ongoing COVID-19 pandemic; the ability of the Company to grow and manage growth profitably, maintain relationships with customers, compete within its industry and retain its key employees; the possibility that the Company may be adversely impacted by other economic conditions (including the rapidly evolving conflict between Russian and the
Use of Non-GAAP Financial Measures
This press release includes certain non-GAAP financial measures that are not prepared in accordance with accounting principles generally accepted in
Condensed Consolidated Balance Sheet Data | |||||||
(in thousands) | |||||||
|
|||||||
(unaudited) | |||||||
ASSETS | |||||||
Cash and cash equivalents | $ |
15,430 |
|
$ |
21,944 |
|
|
Accounts Receivable, net |
|
45,797 |
|
|
27,925 |
|
|
Inventories |
|
39,128 |
|
|
25,806 |
|
|
Prepaid expenses and other current assets |
|
2,821 |
|
|
2,596 |
|
|
Property and equipment, net |
|
22,822 |
|
|
22,177 |
|
|
Right of use asset, net |
|
9,268 |
|
|
5,246 |
|
|
Deferred tax asset |
|
25,103 |
|
|
25,650 |
|
|
Derivative asset - interest rate swap |
|
9,392 |
|
|
- |
|
|
Deposits and other assets |
|
24 |
|
|
10 |
|
|
TOTAL ASSETS | $ |
169,785 |
|
$ |
131,354 |
|
|
LIABILITIES AND STOCKHOLDERS' EQUITY | |||||||
Current portion of long-term debt | $ |
9,685 |
|
|
12,500 |
|
|
Current portion of lease liabilities |
|
1,815 |
|
|
1,119 |
|
|
Accounts payable |
|
12,626 |
|
|
7,058 |
|
|
Accrued expenses |
|
20,424 |
|
|
10,131 |
|
|
Deferred issuance costs |
|
- |
|
|
23,107 |
|
|
Commission payable |
|
14,924 |
|
|
3,089 |
|
|
Bonus payable |
|
7,467 |
|
|
3,512 |
|
|
Long-term debt, net of deferred finance costs |
|
220,532 |
|
|
233,132 |
|
|
Convertible notes, net of debt discount |
|
127,232 |
|
|
126,897 |
|
|
Derivative liability - convertible notes |
|
367 |
|
|
552 |
|
|
Warrant liability |
|
18,908 |
|
|
35,271 |
|
|
Line of credit |
|
10,000 |
|
|
15,000 |
|
|
Earnout liability |
|
16,751 |
|
|
38,427 |
|
|
Lease liabilities |
|
8,133 |
|
|
4,709 |
|
|
Tax receivable agreement liability |
|
25,752 |
|
|
24,500 |
|
|
Total stockholders' (deficit) |
|
(324,831 |
) |
|
(407,650 |
) |
|
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY | $ |
169,785 |
|
$ |
131,354 |
|
Consolidated Statements of Operations | |||||||||||||||
(in thousands, except per share amounts) | |||||||||||||||
(unaudited) | |||||||||||||||
|
|||||||||||||||
Three Months Ended |
Nine Months Ended |
||||||||||||||
2022 |
2021 |
2022 |
2021 |
||||||||||||
Net sales | $ |
103,305 |
|
$ |
66,183 |
|
$ |
284,687 |
|
$ |
192,648 |
|
|||
Operating expenses: | |||||||||||||||
Cost of sales |
|
41,547 |
|
|
30,035 |
|
|
115,318 |
|
|
87,074 |
|
|||
Selling, General and administrative |
|
36,116 |
|
|
14,552 |
|
|
79,325 |
|
|
33,348 |
|
|||
Total operating expenses |
|
77,663 |
|
|
44,587 |
|
|
194,643 |
|
|
120,422 |
|
|||
Income from operations |
|
25,642 |
|
|
21,596 |
|
|
90,044 |
|
|
72,226 |
|
|||
Total other income (expense), net |
|
(3,355 |
) |
|
(2,902 |
) |
|
23,153 |
|
|
(8,830 |
) |
|||
Income before income taxes |
|
22,287 |
|
|
18,694 |
|
|
113,197 |
|
|
63,396 |
|
|||
Income tax provision |
|
(393 |
) |
|
- |
|
|
(3,738 |
) |
|
- |
|
|||
Net income |
|
21,894 |
|
|
18,694 |
|
|
109,459 |
|
|
63,396 |
|
|||
Net income attributable to non-controlling interests |
|
19,077 |
|
|
- |
|
|
93,973 |
|
|
- |
|
|||
Net income attributable to |
$ |
2,817 |
|
$ |
18,694 |
|
$ |
15,486 |
|
$ |
63,396 |
|
|||
Net income per share attributable to Class A common stockholders -basic | $ |
0.18 |
|
|
n/a |
|
$ |
1.02 |
|
|
n/a |
|
|||
Net income per share attributable to Class A common stockholders - diluted | $ |
0.18 |
|
|
n/a |
|
$ |
0.94 |
|
|
n/a |
|
|||
Weighted average shared used to compute net income per share attributable to Class A common stockholders - basic |
|
15,433 |
|
|
n/a |
|
|
15,141 |
|
|
n/a |
|
|||
Weighted average shared used to compute net income per share attributable to Class A common stockholders - diluted |
|
19,662 |
|
|
n/a |
|
|
32,815 |
|
|
n/a |
|
Consolidated Statements of Cash Flows | |||||||
(in thousands) | |||||||
(unaudited) | |||||||
|
|||||||
Nine Months Ended |
|||||||
2022 |
2021 |
||||||
CASH FLOWS FROM OPERATING ACTIVITIES: | |||||||
Net income | $ |
109,459 |
|
$ |
63,396 |
|
|
Adjustments to reconcile net income to net cash provided by operating activities | |||||||
Depreciation |
|
6,577 |
|
|
7,813 |
|
|
Equity-based compensation expense |
|
7,736 |
|
|
1,124 |
|
|
Amortization of deferred finance costs |
|
1,798 |
|
|
1,167 |
|
|
Change in fair value of earnout consideration liability |
|
(21,676 |
) |
|
- |
|
|
Revaluation of warrant liability |
|
(16,363 |
) |
|
- |
|
|
Change in fair value of derivative liability |
|
(185 |
) |
|
- |
|
|
Deferred tax expense |
|
3,191 |
|
|
- |
|
|
Changes in assets and liabilities | |||||||
Accounts receivable |
|
(17,871 |
) |
|
(24,576 |
) |
|
Inventories |
|
(13,322 |
) |
|
3,708 |
|
|
Prepaid expenses and other assets |
|
(225 |
) |
|
216 |
|
|
Accounts payable |
|
5,568 |
|
|
(1,912 |
) |
|
Deposits and other assets |
|
(14 |
) |
|
(5,330 |
) |
|
Accrued expenses |
|
10,293 |
|
|
2,261 |
|
|
Other liabilities |
|
15,885 |
|
|
180 |
|
|
Net cash provided by operating activities |
|
90,851 |
|
|
48,047 |
|
|
CASH FLOWS FROM INVESTING ACTIVITIES: | |||||||
Acquisition of property and equipment |
|
(7,221 |
) |
|
(3,900 |
) |
|
Net cash used in investing activities |
|
(7,221 |
) |
|
(3,900 |
) |
|
CASH FLOWS FROM FINANCING ACTIVITIES: | |||||||
Proceeds from exercise of stock options |
|
2 |
|
|
- |
|
|
Payment of line of credit |
|
(5,000 |
) |
|
(5,000 |
) |
|
Payment of term loan |
|
(16,878 |
) |
|
(18,000 |
) |
|
Distributions |
|
(44,435 |
) |
|
(22,333 |
) |
|
Payment of issuance cost related to business combination |
|
(23,833 |
) |
|
- |
|
|
Net cash used in financing activities |
|
(90,144 |
) |
|
(45,333 |
) |
|
Net decrease in cash and cash equivalents |
|
(6,514 |
) |
|
(1,186 |
) |
|
Cash and cash equivalents, beginning of period |
|
21,944 |
|
|
13,422 |
|
|
Cash and cash equivalents, end of period | $ |
15,430 |
|
$ |
12,236 |
|
|
Supplementary disclosure of cash flow information | |||||||
Cash paid for interest expense | $ |
14,937 |
|
$ |
7,635 |
|
|
Supplemental disclosure of non-cash financing activity: | |||||||
Derivative asset - interest rate swap | $ |
9,392 |
|
$ |
- |
|
Non-GAAP Adjusted EBITDA Reconciliation | |||||||||||||
(in thousands) | |||||||||||||
(unaudited) | |||||||||||||
|
|||||||||||||
|
|||||||||||||
Three Months Ended |
Nine Months Ended |
||||||||||||
2022 |
2021 |
2022 |
2021 |
||||||||||
Net income | $ |
21,894 |
|
$ |
18,694 |
$ |
109,459 |
|
$ |
63,396 |
|||
Add: | |||||||||||||
Depreciation |
|
2,010 |
|
|
2,640 |
|
6,577 |
|
|
7,813 |
|||
Interest expense, net |
|
5,850 |
|
|
2,902 |
|
16,362 |
|
|
8,830 |
|||
Taxes |
|
393 |
|
|
- |
|
3,738 |
|
|
- |
|||
EBITDA | $ |
30,147 |
|
$ |
24,236 |
$ |
136,136 |
|
$ |
80,040 |
|||
Equity compensation expense |
|
3,715 |
|
|
340 |
|
7,736 |
|
|
1,124 |
|||
Mark to market adjustments (1) |
|
(1,204 |
) |
|
- |
|
(38,224 |
) |
|
- |
|||
Adjusted EBITDA | $ |
32,658 |
|
$ |
24,576 |
$ |
105,648 |
|
$ |
81,164 |
|||
|
|||||||||||||
|
|||||||||||||
(1) Includes the changes in fair value of warrant liability, derivative liabilities and earnout consideration liability for the quarter and year ended |
Non-GAAP Adjusted EPS Reconciliation | |||||||||||||||
(in thousands) | |||||||||||||||
(unaudited) | |||||||||||||||
|
|||||||||||||||
|
|||||||||||||||
Three Months Ended |
Nine Months Ended |
||||||||||||||
2022 |
2022 |
||||||||||||||
(in thousands) except per share amounts | |||||||||||||||
Basic | Diluted | Basic | Diluted | ||||||||||||
Net income | $ |
21,894 |
|
$ |
21,894 |
|
$ |
109,459 |
|
$ |
109,459 |
|
|||
Add: provision for income taxes |
|
393 |
|
|
393 |
|
|
3,738 |
|
|
3,738 |
|
|||
Income before Income taxes |
|
22,287 |
|
|
22,287 |
|
|
113,197 |
|
|
113,197 |
|
|||
Income tax expense (1) |
|
(5,266 |
) |
|
(5,266 |
) |
|
(17,432 |
) |
|
(17,432 |
) |
|||
Adjusted net income |
|
17,021 |
|
|
17,021 |
|
|
95,765 |
|
|
95,765 |
|
|||
Less: mark-to-market adjustments (2) |
|
(957 |
) |
|
(957 |
) |
|
(38,040 |
) |
|
(38,040 |
) |
|||
Add: stock-based compensation |
|
3,715 |
|
|
3,715 |
|
|
7,736 |
|
|
7,736 |
|
|||
Adjusted net income | $ |
19,779 |
|
$ |
19,779 |
|
$ |
65,461 |
|
$ |
65,461 |
|
|||
Common shares outstanding used in computing earnings per share, basic: | |||||||||||||||
Class A and Class B common shares (3) |
|
76,020 |
|
|
76,020 |
|
|
75,728 |
|
|
75,728 |
|
|||
Common shares outstanding used in computing earnings per share, diluted: | |||||||||||||||
Warrants (Public and Private) (4) |
|
- |
|
|
8,094 |
|
|
- |
|
|
8,094 |
|
|||
Options and restricted common shares |
|
- |
|
|
4,229 |
|
|
- |
|
|
4,674 |
|
|||
Total Shares outstanding used in computing adjusted earnings per share |
|
76,020 |
|
|
88,343 |
|
|
75,728 |
|
|
88,496 |
|
|||
Adjusted earnings per share (5) | $ |
0.26 |
|
$ |
0.22 |
|
$ |
0.86 |
|
$ |
0.74 |
|
|||
|
|||||||||||||||
|
|||||||||||||||
1) Calculated using the Company's blended tax rate. | |||||||||||||||
2) Includes the changes in fair value of warrant liability and earnout consideration liability. | |||||||||||||||
3) Assumes both Class B shares and Class A shares participate in earnings and are outstanding at the end of the period. | |||||||||||||||
4) Assumes treasury stock method, valuation at assumed fair market value of |
|||||||||||||||
5) The Company did not include the effect of Exchangeable Notes to its total shares outstanding used in diluted adjusted net income per share. |
View source version on businesswire.com: https://www.businesswire.com/news/home/20221102005342/en/
Corporate Contact
Head of Communications,
(908) 898-8887
apiniella@composecure.com
Investor Relations Contact
Elevate IR
(720) 330-2829
ir@composecure.com
Source:
FAQ
What were the financial highlights for CMPO in Q3 2022?
What is CMPO's adjusted EBITDA forecast for 2022?
How much did CMPO's international sales grow in Q3 2022?